Legend Biotech Corporation
LEGN
$35.46
-$0.17-0.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 796.24M | 725.29M | 620.98M | 514.11M | 450.18M |
| Total Other Revenue | 598.00K | 3.02M | 6.26M | 6.07M | 5.81M |
| Total Revenue | 796.84M | 728.30M | 627.24M | 520.18M | 455.99M |
| Cost of Revenue | 698.91M | 665.69M | 648.13M | 607.90M | 596.25M |
| Gross Profit | 97.93M | 62.61M | -20.88M | -87.72M | -140.26M |
| SG&A Expenses | 315.77M | 300.54M | 284.26M | 263.52M | 233.15M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.01B | 966.23M | 932.39M | 871.43M | 829.40M |
| Operating Income | -217.84M | -237.93M | -305.15M | -351.24M | -373.41M |
| Income Before Tax | -304.30M | -197.48M | -158.13M | -345.46M | -287.07M |
| Income Tax Expenses | 21.03M | 20.67M | 18.89M | 2.67M | -2.05M |
| Earnings from Continuing Operations | -325.33 | -218.15 | -177.03 | -348.13 | -285.01 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -325.33M | -218.15M | -177.03M | -348.13M | -285.01M |
| EBIT | -217.84M | -237.93M | -305.15M | -351.24M | -373.41M |
| EBITDA | -207.76M | -227.09M | -293.04M | -339.28M | -361.15M |
| EPS Basic | -3.54 | -2.38 | -1.94 | -3.82 | -3.13 |
| Normalized Basic EPS | -1.02 | -0.65 | -0.53 | -1.18 | -0.99 |
| EPS Diluted | -3.54 | -2.38 | -1.94 | -3.82 | -3.14 |
| Normalized Diluted EPS | -1.03 | -0.67 | -0.54 | -1.18 | -0.99 |
| Average Basic Shares Outstanding | 734.50M | 732.97M | 731.21M | 729.72M | 727.97M |
| Average Diluted Shares Outstanding | 376.29M | 375.52M | 374.65M | 364.86M | 363.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |